Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona Lalloo

Showing results (11-20 of 162) with videos related to

Pageof 17
Sort By:
European Journal of Human Genetics : EJHG|April 16, 2009
Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary riskD Gareth R Evans, Richard Clayton, Paul Donnai, et al.
Journal of Medical Genetics|May 18, 2010
BRCA1, BRCA2 and CHEK2 c.1100 delC mutations in patients with double primaries of the breasts and/or ovariesD Gareth Evans, Munaza Ahmed, Stuart Bayliss, et al.
European Journal of Cancer (Oxford, England : 1990)|November 25, 2019
Challenging the believed proportion of ovarian cancer attributable to BRCA2 versus BRCA1 pathogenic variantsNicola Flaum, Emma J Crosbie, Emma R Woodward, et al.
Surgical Neurology International|October 7, 2024
Cerebellopontine angle craniopharyngioma in familial adenomatous polyposisSayantan Bose, James Balogun, Daniel du Plessis, et al.
Journal of the National Cancer Institute|February 21, 2002
Re: risk-reduction mastectomy: clinical issues and research needsD Gareth Evans, Anthony Howell, Andrew Baildam, et al.
Journal of Medical Genetics|February 19, 2025
Impact of NICE Guideline NG241 'Ovarian Cancer: identifying and managing familial and genetic risk' on a regional NHS family history and clinical genetics serviceAlexander Roe, Andrea Forman, Fiona Lalloo, et al.
BMC Cancer|June 3, 2008
Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the familyD Gareth Evans, Andrew Shenton, Emma Woodward, et al.
Journal of Medical Genetics|May 28, 2026
Identification of Lynch syndrome among people newly diagnosed with endometrial cancer: a prospective auditJean-Ellen Johnson, Sarah Milliken, James Bolton, et al.
Clinical Kidney Journal|June 14, 2016
Muir-Torre syndrome in a haemodialysis patientEvonne D Godfrey, Robert A Coward, Deepa Gharpuray-Pandit, et al.
Breast Cancer Research and Treatment|July 4, 2012
High sensitivity for BRCA1/2 mutations in breast/ovarian kindreds: are there still other breast/ovary genes to be discovered?Miriam J Smith, Franchesca L Gifford, Fiona Lalloo, et al.
Pageof 17

Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
European Journal of Human Genetics : EJHG|April 16, 2009
Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary riskD Gareth R Evans, Richard Clayton, Paul Donnai, et al.
Journal of Medical Genetics|May 18, 2010
BRCA1, BRCA2 and CHEK2 c.1100 delC mutations in patients with double primaries of the breasts and/or ovariesD Gareth Evans, Munaza Ahmed, Stuart Bayliss, et al.
European Journal of Cancer (Oxford, England : 1990)|November 25, 2019
Challenging the believed proportion of ovarian cancer attributable to BRCA2 versus BRCA1 pathogenic variantsNicola Flaum, Emma J Crosbie, Emma R Woodward, et al.
Surgical Neurology International|October 7, 2024
Cerebellopontine angle craniopharyngioma in familial adenomatous polyposisSayantan Bose, James Balogun, Daniel du Plessis, et al.
Journal of the National Cancer Institute|February 21, 2002
Re: risk-reduction mastectomy: clinical issues and research needsD Gareth Evans, Anthony Howell, Andrew Baildam, et al.
Journal of Medical Genetics|February 19, 2025
Impact of NICE Guideline NG241 'Ovarian Cancer: identifying and managing familial and genetic risk' on a regional NHS family history and clinical genetics serviceAlexander Roe, Andrea Forman, Fiona Lalloo, et al.
BMC Cancer|June 3, 2008
Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the familyD Gareth Evans, Andrew Shenton, Emma Woodward, et al.
Journal of Medical Genetics|May 28, 2026
Identification of Lynch syndrome among people newly diagnosed with endometrial cancer: a prospective auditJean-Ellen Johnson, Sarah Milliken, James Bolton, et al.
Clinical Kidney Journal|June 14, 2016
Muir-Torre syndrome in a haemodialysis patientEvonne D Godfrey, Robert A Coward, Deepa Gharpuray-Pandit, et al.
Breast Cancer Research and Treatment|July 4, 2012
High sensitivity for BRCA1/2 mutations in breast/ovarian kindreds: are there still other breast/ovary genes to be discovered?Miriam J Smith, Franchesca L Gifford, Fiona Lalloo, et al.
Pageof 17